Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Hikma Pharmaceuticals Plc (HKMPF) had Cash Flow from Financial Activities of $-25.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.64B |
|
$2.58B |
|
$4.16B |
|
$5.67B |
|
$1.45B |
|
$1.49B |
|
$1.61B |
|
$3.06B |
|
$2.61B |
|
$1.44B |
|
$2.61B |
|
-- |
|
| Cash Flow Statement Financials | |
$436.00M |
|
$-388.00M |
|
|
Cash Flow from Financial Activities |
$-25.00M |
$188.00M |
|
$217.00M |
|
$29.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|